Genistein and Tyrphostin AG556 Decrease Ultra‐rapidly Activating Delayed Rectifier K+ Current of Human Atria by Inhibiting EGF Receptor Tyrosine Kinase

Guo-Sheng Xiao,Yan-Hui Zhang,Wei Wu,Hai-Ying Sun,Yan Wang,Gui-Rong Li
DOI: https://doi.org/10.1111/bph.13710
IF: 7.3
2017-01-01
British Journal of Pharmacology
Abstract:Background and PurposeThe ultra‐rapidly activating delayed rectifier K+ current IKur (encoded by Kv1.5 or KCNA5) plays an important role in human atrial repolarization. The present study investigates the regulation of this current by protein tyrosine kinases (PTKs).Experimental ApproachWhole‐cell patch voltage clamp technique and immunoprecipitation and Western blotting analysis were used to investigate whether the PTK inhibitors genistein, tyrphostin AG556 (AG556) and PP2 regulate human atrial IKur and hKv1.5 channels stably expressed in HEK 293 cells.Key ResultsHuman atrial IKur was decreased by genistein (a broad‐spectrum PTK inhibitor) and AG556 (a highly selective EGFR TK inhibitor) in a concentration‐dependent manner. Inhibition of IKur induced by 30 μM genistein or 10 μM AG556 was significantly reversed by 1 mM orthovanadate (a protein tyrosine phosphatase inhibitor). Similar results were observed in HEK 293 cells stably expressing hKv1.5 channels. On the other hand, the Src family kinase inhibitor PP2 (1 μM) slightly enhanced IKur and hKv1.5 current, and the current increase was also reversed by orthovanadate. Immunoprecipitation and Western blotting analysis showed that genistein, AG556, and PP2 decreased tyrosine phosphorylation of hKv1.5 channels and that the decrease was countered by orthovanadate.Conclusion and ImplicationsThe PTK inhibitors genistein and AG556 decrease human atrial IKur and cloned hKv1.5 channels by inhibiting EGFR TK, whereas the Src kinase inhibitor PP2 increases IKur and hKv1.5 current. These results imply that EGFR TK and the soluble Src kinases may have opposite effects on human atrial IKur.
What problem does this paper attempt to address?